IL137610A0 - Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins - Google Patents
Streptomyces avermitilis gene directing the ratio of b2:b1 avermectinsInfo
- Publication number
- IL137610A0 IL137610A0 IL13761099A IL13761099A IL137610A0 IL 137610 A0 IL137610 A0 IL 137610A0 IL 13761099 A IL13761099 A IL 13761099A IL 13761099 A IL13761099 A IL 13761099A IL 137610 A0 IL137610 A0 IL 137610A0
- Authority
- IL
- Israel
- Prior art keywords
- avermectins
- ratio
- streptomyces avermitilis
- gene directing
- avermitilis gene
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
- C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
- C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/76—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Actinomyces; for Streptomyces
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
- C12P17/181—Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7463698P | 1998-02-13 | 1998-02-13 | |
| PCT/IB1999/000130 WO1999041389A1 (en) | 1998-02-13 | 1999-01-25 | Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL137610A0 true IL137610A0 (en) | 2001-07-24 |
Family
ID=22120706
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13761099A IL137610A0 (en) | 1998-02-13 | 1999-01-25 | Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins |
| IL183596A IL183596A0 (is) | 1998-02-13 | 2007-05-31 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL183596A IL183596A0 (is) | 1998-02-13 | 2007-05-31 |
Country Status (32)
| Country | Link |
|---|---|
| EP (1) | EP1053335A1 (is) |
| JP (2) | JP2002503473A (is) |
| KR (3) | KR20040099389A (is) |
| CN (2) | CN1297485A (is) |
| AP (1) | AP9901463A0 (is) |
| AR (1) | AR018085A1 (is) |
| AU (1) | AU752343C (is) |
| BG (1) | BG64911B1 (is) |
| BR (1) | BR9907893A (is) |
| CA (2) | CA2320031A1 (is) |
| CO (1) | CO5070698A1 (is) |
| DZ (1) | DZ2720A1 (is) |
| EA (1) | EA003905B1 (is) |
| GT (1) | GT199900014A (is) |
| HN (1) | HN1999000008A (is) |
| HR (1) | HRP20000539A2 (is) |
| HU (1) | HUP0100784A3 (is) |
| IL (2) | IL137610A0 (is) |
| IS (1) | IS5567A (is) |
| MA (1) | MA24760A1 (is) |
| NO (1) | NO20004044L (is) |
| NZ (2) | NZ518657A (is) |
| OA (1) | OA11449A (is) |
| PA (1) | PA8467601A1 (is) |
| PE (1) | PE20000352A1 (is) |
| PL (1) | PL194270B1 (is) |
| SK (1) | SK11722000A3 (is) |
| TN (1) | TNSN99017A1 (is) |
| TW (1) | TW585910B (is) |
| WO (1) | WO1999041389A1 (is) |
| YU (1) | YU50900A (is) |
| ZA (1) | ZA991138B (is) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6248579B1 (en) * | 1998-02-13 | 2001-06-19 | Pfizer Inc | Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins |
| KR20040099389A (ko) * | 1998-02-13 | 2004-11-26 | 화이자 프로덕츠 인코포레이티드 | 스트렙토마이세스 하이그로스코피쿠스 유전자 |
| DE60031126T2 (de) | 1999-08-12 | 2007-02-08 | Pfizer Products Inc., Groton | Streptomyces avermitilis gen zum regulieren des verhältnisses der b2:b1 avermectinen |
| US7630836B2 (en) | 2001-05-30 | 2009-12-08 | The Kitasato Institute | Polynucleotides |
| EP1476539B1 (en) | 2002-02-12 | 2009-03-25 | Pfizer Products Inc. | Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins |
| CN107338210B (zh) * | 2017-09-05 | 2021-08-17 | 天津科技大学 | 一种阿维链霉菌合成培养基及其发酵液的制备方法 |
| CN111269296B (zh) * | 2020-03-06 | 2021-11-05 | 山东大学 | 一种nLsA蛋白及其结构基因和应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE434277B (sv) * | 1976-04-19 | 1984-07-16 | Merck & Co Inc | Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis |
| US4429042A (en) * | 1978-09-08 | 1984-01-31 | Merck & Co., Inc. | Strain of Streptomyces for producing antiparasitic compounds |
| IN167980B (is) * | 1987-01-23 | 1991-01-19 | Pfizer | |
| DE3881147T2 (de) * | 1987-10-23 | 1993-09-02 | Pfizer | Verfahren zur herstellung von aglykonen von avermectin und sie enthaltende kulturen. |
| JPH0747171B2 (ja) * | 1988-09-20 | 1995-05-24 | 株式会社東芝 | 圧延機の設定方法および装置 |
| US5252474A (en) * | 1989-03-31 | 1993-10-12 | Merck & Co., Inc. | Cloning genes from Streptomyces avermitilis for avermectin biosynthesis and the methods for their use |
| DE69023036T2 (de) * | 1989-03-31 | 1996-06-13 | Merck & Co Inc | Klonierung von Streptomyces avermitilis Genen zur Biosynthese von Avermectin und Verfahren zu ihrer Verwendung. |
| JP2888586B2 (ja) * | 1990-03-05 | 1999-05-10 | 社団法人北里研究所 | エバーメクチンの特定成分を選択生産するための微生物およびその選択的製造法 |
| FI942725A (fi) * | 1993-12-16 | 1995-06-17 | Pfizer | Haaraketjuista alfaketohappodenydrogenaasikompleksia koodaavia geenejä Streptomyces avermitiliksesta |
| KR20040099389A (ko) * | 1998-02-13 | 2004-11-26 | 화이자 프로덕츠 인코포레이티드 | 스트렙토마이세스 하이그로스코피쿠스 유전자 |
-
1999
- 1999-01-25 KR KR10-2004-7015691A patent/KR20040099389A/ko active Search and Examination
- 1999-01-25 AU AU18878/99A patent/AU752343C/en not_active Ceased
- 1999-01-25 KR KR10-2004-7008310A patent/KR20040053390A/ko active Search and Examination
- 1999-01-25 CN CN99805027A patent/CN1297485A/zh active Pending
- 1999-01-25 EP EP99900270A patent/EP1053335A1/en not_active Withdrawn
- 1999-01-25 WO PCT/IB1999/000130 patent/WO1999041389A1/en not_active Application Discontinuation
- 1999-01-25 BR BR9907893-7A patent/BR9907893A/pt not_active Application Discontinuation
- 1999-01-25 IL IL13761099A patent/IL137610A0/xx unknown
- 1999-01-25 CA CA002320031A patent/CA2320031A1/en not_active Abandoned
- 1999-01-25 YU YU50900A patent/YU50900A/sh unknown
- 1999-01-25 EA EA200000758A patent/EA003905B1/ru not_active IP Right Cessation
- 1999-01-25 KR KR10-2000-7008870A patent/KR100499214B1/ko not_active IP Right Cessation
- 1999-01-25 HU HU0100784A patent/HUP0100784A3/hu not_active Application Discontinuation
- 1999-01-25 NZ NZ518657A patent/NZ518657A/en unknown
- 1999-01-25 CN CNA2004100054154A patent/CN1521180A/zh active Pending
- 1999-01-25 NZ NZ505676A patent/NZ505676A/xx unknown
- 1999-01-25 SK SK1172-2000A patent/SK11722000A3/sk unknown
- 1999-01-25 CA CA002521289A patent/CA2521289A1/en not_active Abandoned
- 1999-01-25 PL PL99342468A patent/PL194270B1/pl not_active IP Right Cessation
- 1999-01-25 JP JP2000531570A patent/JP2002503473A/ja active Pending
- 1999-01-26 PA PA19998467601A patent/PA8467601A1/es unknown
- 1999-02-01 GT GT199900014A patent/GT199900014A/es unknown
- 1999-02-05 HN HN1991000008A patent/HN1999000008A/es unknown
- 1999-02-08 PE PE1999000099A patent/PE20000352A1/es not_active Application Discontinuation
- 1999-02-09 TW TW088102005A patent/TW585910B/zh active
- 1999-02-10 DZ DZ990021A patent/DZ2720A1/xx active
- 1999-02-10 TN TNTNSN99017A patent/TNSN99017A1/fr unknown
- 1999-02-10 MA MA25460A patent/MA24760A1/fr unknown
- 1999-02-11 AR ARP990100571A patent/AR018085A1/es unknown
- 1999-02-11 AP APAP/P/1999/001463A patent/AP9901463A0/en unknown
- 1999-02-12 CO CO99008652A patent/CO5070698A1/es unknown
- 1999-02-12 ZA ZA9901138A patent/ZA991138B/xx unknown
-
2000
- 2000-07-20 IS IS5567A patent/IS5567A/is unknown
- 2000-08-04 OA OA1200000217A patent/OA11449A/en unknown
- 2000-08-11 HR HR20000539A patent/HRP20000539A2/hr not_active Application Discontinuation
- 2000-08-11 NO NO20004044A patent/NO20004044L/no not_active Application Discontinuation
- 2000-09-12 BG BG104759A patent/BG64911B1/bg unknown
-
2004
- 2004-04-27 JP JP2004130624A patent/JP4011036B2/ja not_active Expired - Fee Related
-
2007
- 2007-05-31 IL IL183596A patent/IL183596A0/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0104192A3 (en) | Novel macrolide antibiotics | |
| HK1168383A1 (en) | Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins | |
| HUP0100784A3 (en) | Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins | |
| HUP9903073A3 (en) | Streptomyces avermitilis regulatory genes for increased avermectin production | |
| IL147562A0 (en) | Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins | |
| AU4549999A (en) | Novel polyene macrolide compounds and uses | |
| HUP0202487A2 (en) | Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins | |
| AU1974900A (en) | Macrolide intermediates in the preparation of clarithromycin | |
| AU1161500A (en) | Macrolide intermediates | |
| EP1206477A4 (en) | CLONING OF THE STREPTOMYCES AVERMITILIS GENES FOR THE GLYCOSYLATION OF AVERMECTIN AGLYCONES | |
| AU2002323990A1 (en) | Adenosine derivatives | |
| AU2003204618A1 (en) | Novel Erythromycin Derivatives | |
| AU2003204615A1 (en) | Novel Erythromycin Derivatives | |
| AU2003204619A1 (en) | Novel Erythromycin Derivatives | |
| AU4831199A (en) | Erythromycin compositions |